Moreover, the LTBI rate in our study was 13.4% (18/134), similar to previous studies: 12/110 (11%) [15] and 10/101 (10%) [16] in Taiwan among TNF-blockers users for psoriasis. This evidence concerns the gene TNF and psoriasis.